Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Özbek Ventures GmbH is an angel investor organization based in Berlin, Germany, focusing on the med-tech and technology sectors. The firm has a portfolio of 15 companies and engages in co-investing through partnerships like the Berlin Angel Fund. Their investment strategy emphasizes innovative solutions that address healthcare challenges.
Özbek Ventures primarily invests in the healthcare, AI, and SaaS sectors, supporting companies at various stages of development. They seek out innovative solutions that enhance healthcare applications and technology. Typical check sizes and specific stage preferences are not disclosed.
Notable portfolio companies include Diametos, which develops AI solutions for snoring diagnosis, and Scopis, the first med-tech company to commercialize surgical navigation systems with Augmented Reality, acquired by Stryker in 2017. Other significant investments include Agrimand, a digital marketplace for farmers that exited in 2022, and saasmetrix, a SaaS management tool acquired by USU GmbH in March 2025.
Email your pitch deck to info@oezbek-ventures.com for consideration.
Özbek Ventures typically participates in rounds but does not exclusively lead them. They often co-invest alongside other funds, such as the Berlin Angel Fund.
Özbek Ventures is open to follow-on investments, particularly in companies that demonstrate significant growth and innovation potential in their respective sectors.
The specific size of Özbek Ventures' current fund is not publicly disclosed, but they maintain a portfolio of 15 companies across various stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.